As biomarkers, CD44+/CD24-/low breast cells have been shown to have tumor-initiating properties in breast cancer [21], show enhanced invasive properties [22], and are more likely to become resistant to radiation therapy [23]. This evidence concerns the gene CD44 and neoplasm.